Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RCVS publishes response to CMA working papers
RCVS believes that mandatory practice regulation is needed to protect consumers.
The regulator raised concern about the CMA’s approach.

The Royal College of Veterinary Surgeons (RCVS) has released its response to the working papers published by the Competition and Markets’ Authority (CMA) in February.

The regulator has criticised CMA’s decision to investigate the veterinary sector as ‘household services’, rather than treating it as a health and social care provider.

In its response, RCVS describes the veterinary sector as ‘multifaceted’, rather than a commodity market. It explains that, as a regulator, it is responsible for maintaining the standards of a number of complex professions.

RCVS says that its role and remit as ‘more closely comparable’ to regulators of solicitors, architects and human healthcare professionals. It believes that it can not be compared to regulators with statutory duties beyond the education, registration, standards and discipline of professionals.

The regulator has also warned CMA against making decisions solely in the interests of the consumer.

It references a number of other factors involved in veterinary decisions, relating to public health, animal health, animal welfare and environmental health. RCVS says that, in its own standards, it allows veterinary professionals autonomy while ‘safeguarding the public interest’.

RCVS highlights key differences between the NHS and the provision of veterinary services. It warns that, with the range of services offered freely on the NHS, pet owners often remain unaware of the actual prices of human treatments.

As a result, veterinary care can be considered as a ‘quasi-public service’. Without meaningful comparators, RCVS warns that consumers will often find prices to be ‘very high’.

It argues that many consumers consider 24-hour emergency services to be a national necessity. Provided by private practitioners, it can be costly for practices to manage this sustainably.

RCVS maintains its position that mandatory practice regulation is the most effective way for it to protect consumers. It is continuing its campaign for this to be implemented through legislative reform and, in the meantime, has expressed willing to work with the CMA on short-term remedies.

However, RCVS enforces that these remedies should be ‘proportionate, enforceable and effective across all veterinary settings’, with consideration of the unintended consequences they might have on veterinary costs.

RCVS’ full response to the CMA’s working papers can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.